Drug intelligence / Profile preview

Lianhua Yuping

Lead developer
Yiling Pharmaceutical
Administration
Oral
01

Overview

Lianhua Yuping (specifically developed as Lianhua Yuping Granules) is an innovative traditional Chinese medicine (TCM) formulation developed by Yiling Pharmaceutical. It is formulated based on the collateral disease theory (络病理论) and is derived from a combination of three classic TCM formulas: Yuping Feng San (玉屏风散), Guizhi Decoction (桂枝汤), and Yinqiao Powder (银翘散). The formulation is designed to treat the common cold with qi deficiency syndrome (感冒气虚证) by replenishing qi, consolidating the defensive exterior (益气固卫), expelling wind, and resolving toxins (祛风解毒). It is currently in Phase II clinical development in China.

Brand names
Lianhua Yuping Herbal Supplement Powder
Other names
Lianhua Yuping Granules连花御屏颗粒
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)CaM (Calmodulin)CAMK2B (Calcium/calmodulin-dependent protein kinase type II subunit beta)CREB1 (cAMP response element-binding protein 1)EGFR (Epidermal growth factor receptor)HDAC1 (Histone Deacetylase 1)NFKB1 (NF-κB1)PRKCA (Protein kinase C alpha)

Beyond the preview

Go deeper on Lianhua Yuping.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lianhua Yuping.

Work on Lianhua Yuping? Claim this page to correct or add information. Claim this page

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call